Shanton Pharma Holdings
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
116 Village Blvd Ste 210, Princeton, New...Phone Number
(510) 386-2891Website
www.shantonpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Shanton Pharma Holdings
Shanton Pharma is a clinical-stage biotech company focused on developing innovative medicines to address unmet clinical needs related to gout, hyperuricemia, and pruritus. Founded in 2016, the company aims to eliminate gout and improve patient outcomes through advanced drug research and development. With a strong pipeline of clinical and preclinical programs, Shanton Pharma is dedicated to bringing new treatments to the medical community. Their experienced management team is committed to the commercialization of their core products.Explore more
Shanton Pharma Holdings Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shanton Pharma Holdings your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Shanton Pharma Holdings recently announced quarterly report
Check out if Shanton Pharma Holdings is spiking on competitors!
Check if Shanton Pharma Holdings has recently received funding, and reach out quickly before it becomes old news!
Shanton Pharma Holdings, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Shanton Pharma Holdings had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Shanton Pharma Holdings has new funding data
Congratulate Masked Content for being promoted to Masked Content at Shanton Pharma Holdings
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Shanton Pharma Holdings launches new products
Recommended Actions
Find VP level buyers at Shanton Pharma Holdings
Find 2 more new buyers
Compare Similar Companies to Shanton Pharma Holdings
Compare insights from companies similar to Shanton Pharma Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Shanton Pharma Holdings is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Shanton Pharma Holdings is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Shanton Pharma Holdings.
Shanton Pharma Holdings Tech Stack
A closer look at the technologies used by Shanton Pharma Holdings
Shanton Pharma Holdings News & Media
Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has...Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has...Shanton to Present Topline Data from Phase 2b Study with SAP-001 in Refractory Gout Patients at EULAR 2025 Congress
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., May 19, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that it will be presenting topline data of its phase 2b study in refractory gout patients at the annual EULAR Congress in Barcelona on June 14. EULAR, the European Alliance of Associations for Rheumatology holds its annual cShanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline data of a Phase 2b study in refractory gout patients with its investigational drug SAP-001 that uses a First-in-Class Mechanism of Action targeting a distinct kidney transporter. "We are excited and very pleased wi
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shanton Pharma Holdings
Sign Up For FreeTo access detailed company insights
Shanton Pharma is a clinical-stage biotech company focused on developing innovative medicines to address unmet clinical needs related to gout, hyperuricemia, and pruritus. Founded in 2016, the company aims to eliminate gout and improve patient outcomes through advanced drug research and development. With a strong pipeline of clinical and preclinica... Read More
